Lianhe Aigen has been awarded the Platinum Medal in the latest assessment by EcoVadis, a globally recognized sustainability rating agency, placing the company among the top 1% of all companies assessed worldwide.

The newly unveiled synthesizer serves as the core hub of the strategic production line, undertaking key synthesis processes and quality control functions.

As a trusted partner in the small-molecule CDMO space, we continue to strengthen our core business while proactively expanding into new frontiers—including oligonucleotide therapeutics—to build a more diversified service capability matrix.

Safety is the cornerstone of development and the most solemn commitment we make to every employee. This June, Lianhe Aigen launched an in-depth series of activities for Workplace Safety Month under the theme “Everyone Speaks Safety, Everyone Knows Emergency Response — Identify and Address Risks and Hazards.”

CPHI China 2026 was a wonderful gathering, and more importantly, it marks the beginning of lasting collaborations. We look forward to transforming the consensus reached at the exhibition into tangible cooperation outcomes.

Lianhe Aigen has always believed that the ultimate purpose of dedicated R&D and rigorous manufacturing is to protect lives and benefit humanity. And this commitment to caring for people extends from our production lines to society at large—this is not only our bounden duty, but also our enduring promise.